BSX
$103.79
Revenue | $4561Mn |
Net Profits | $566Mn |
Net Profit Margins | 12.41% |
PE Ratio | 80.64 |
Boston Scientific Corp.’s revenue jumped 22.44% since last year same period to $4561Mn in the Q4 2024. On a quarterly growth basis, Boston Scientific Corp. has generated 8.36% jump in its revenue since last 3-months.
Boston Scientific Corp.’s net profit jumped 12.08% since last year same period to $566Mn in the Q4 2024. On a quarterly growth basis, Boston Scientific Corp. has generated 20.94% jump in its net profits since last 3-months.
Boston Scientific Corp.’s net profit margin fell -8.46% since last year same period to 12.41% in the Q4 2024. On a quarterly growth basis, Boston Scientific Corp. has generated 11.61% jump in its net profit margins since last 3-months.
Boston Scientific Corp.’s price-to-earnings ratio after this Q4 2024 earnings stands at 80.64.
EPS Estimate Current Quarter | 0.66 |
EPS Estimate Current Year | 0.66 |
Boston Scientific Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.66 - a 11.34% jump from last quarter’s estimates.
Boston Scientific Corp.’s earning per share (EPS) estimates for the current year stand at 0.66.
Earning Per Share (EPS) | 0.7 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.09 |
Boston Scientific Corp.’s earning per share (EPS) jumped 27.27% since last year same period to 0.7 in the Q4 2024. This indicates that the Boston Scientific Corp. has generated 27.27% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Boston Scientific Corp.’s return on assets (ROA) stands at 0.05.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Boston Scientific Corp.’s return on equity (ROE) stands at 0.09.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-11-01 | 0.59 | 0.63 | 6.78% |
2025-02-18 | 0.66 | 0.7 | 6.56% |
2024-05-01 | 0.51 | 0.56 | 9.8% |
2024-08-01 | 0.58 | 0.62 | 6.9% |